Paper36911719
New-age vaccine adjuvants, their development, and future perspective.
Verma SK and 6 others. Front Immunol, 2023. Cited by 154 papers, by iCite.
Cite this record
ConductScience Library. New-age vaccine adjuvants, their development, and future perspective. Papers, record 36911719. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36911719
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adjuvants, Vaccine | Major topic |
| Vaccines | Major topic |
| Humans | |
| Immunization | |
| Vaccination | |
| Adjuvants, Immunologic |
Source PubMed
References210
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22153065 | Bridging innate and adaptive immunity. | Cell | 2011 | https://conductscience.org/library/papers/22153065 | PubMed |
| 2 | 22902784 | A randomized control trial comparing immunogenicity, safety, and preference for self- versus nurse-administered intradermal influenza vaccine. | Vaccine | 2012 | https://conductscience.org/library/papers/22902784 | PubMed |
| 3 | 16188325 | (How) do aluminium adjuvants work? | Immunol Lett | 2006 | https://conductscience.org/library/papers/16188325 | PubMed |
| 4 | 22326899 | Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice. | Vaccine | 2012 | https://conductscience.org/library/papers/22326899 | PubMed |
| 5 | 28436755 | Modes of Action for Mucosal Vaccine Adjuvants. | Viral Immunol | 2017 | https://conductscience.org/library/papers/28436755 | PubMed |
| 6 | 24040248 | Aluminum hydroxide adjuvant differentially activates the three complement pathways with major involvement of the alternative pathway. | PLoS One | 2013 | https://conductscience.org/library/papers/24040248 | PubMed |
| 7 | 27922851 | Future prospects for new vaccines against sexually transmitted infections. | Curr Opin Infect Dis | 2017 | https://conductscience.org/library/papers/27922851 | PubMed |
| 8 | 18412160 | Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells. | Eur J Immunol | 2008 | https://conductscience.org/library/papers/18412160 | PubMed |
| 9 | 10618529 | Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes. | Vaccine | 2000 | https://conductscience.org/library/papers/10618529 | PubMed |
| 10 | 19416838 | Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19416838 | PubMed |
| 11 | 34315484 | Liposomes for malaria management: the evolution from 1980 to 2020. | Malar J | 2021 | https://conductscience.org/library/papers/34315484 | PubMed |
| 12 | 26372857 | Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21. | Vaccine | 2015 | https://conductscience.org/library/papers/26372857 | PubMed |
| 13 | 25765967 | The novel adjuvant dmLT promotes dose sparing, mucosal immunity and longevity of antibody responses to the inactivated polio vaccine in a murine model. | Vaccine | 2015 | https://conductscience.org/library/papers/25765967 | PubMed |
| 14 | 12414756 | Adjuvant activity of emulsan, a secreted lipopolysaccharide from acinetobacter calcoaceticus. | Clin Diagn Lab Immunol | 2002 | https://conductscience.org/library/papers/12414756 | PubMed |
| 15 | 18194079 | Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients. | Expert Opin Biol Ther | 2008 | https://conductscience.org/library/papers/18194079 | PubMed |
| 16 | 33824489 | Emerging concepts in the science of vaccine adjuvants. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33824489 | PubMed |
| 17 | 32228108 | Army Liposome Formulation (ALF) family of vaccine adjuvants. | Expert Rev Vaccines | 2020 | https://conductscience.org/library/papers/32228108 | PubMed |
| 18 | 21490151 | Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production. | J Immunol | 2011 | https://conductscience.org/library/papers/21490151 | PubMed |
| 19 | 18650390 | Molecular and cellular signatures of human vaccine adjuvants. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18650390 | PubMed |
| 20 | 16204643 | The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells. | J Leukoc Biol | 2005 | https://conductscience.org/library/papers/16204643 | PubMed |
Cited by106
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 154 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42827211 | Computational systems immunology and multi-scale modeling for the design of a Multi-Epitope Vaccine (MEV) against emerging multidrug-resistant Klebsiella michiganensis. | Int Microbiol | 2026 | https://conductscience.org/library/papers/42827211 | PubMed |
| 42801348 | Empowering cancer therapy: the promise of natural adjuvants. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42801348 | PubMed |
| 42646699 | Advances in Therapeutic Melanoma Vaccines (2010-2025). | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42646699 | PubMed |
| 42534944 | KA101 outperforms other clinical adjuvants in inducing balanced Th1/Th2 immunity and robust B cell responses to varicella-zoster virus glycoprotein E. | Front Immunol | 2026 | https://conductscience.org/library/papers/42534944 | PubMed |
| 42534843 | Licensed and investigational TLR4 agonists as vaccine adjuvants: structural basis, clinical progress, and future directions. | Front Immunol | 2026 | https://conductscience.org/library/papers/42534843 | PubMed |
| 42489461 | Respiratory mucosal vaccines for emerging viruses: promise and challenges. | J Virol | 2026 | https://conductscience.org/library/papers/42489461 | PubMed |
| 42476979 | High-throughput antigen discovery using Functional Genomic Vaccinology (FGV) identifies protective Streptococcus pneumoniae vaccine candidates. | Nat Commun | 2026 | https://conductscience.org/library/papers/42476979 | PubMed |
| 42402538 | Applications of Recombinant DNA Technology in Medicine: A Comprehensive Review. | Mol Biotechnol | 2026 | https://conductscience.org/library/papers/42402538 | PubMed |
| 42357435 | α-Synuclein-Targeted Immunotherapies in Parkinson's Disease: In Silico, In Vitro and Clinical Perspectives. | Molecules | 2026 | https://conductscience.org/library/papers/42357435 | PubMed |
| 42347601 | Charting the Path Forward for HIV Immune-Based Prevention: Contributions of the Division of AIDS at NIAID. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42347601 | PubMed |
| 42340354 | Salmonella-derived OMVs as a vaccine platform for Riemerella anatipestifer outer membrane proteins to prevent infection in ducks. | Appl Environ Microbiol | 2026 | https://conductscience.org/library/papers/42340354 | PubMed |
| 42159745 | CpG-ODN/Coa-ASC16 nanostructured adjuvant platform as a safe and effective alternative in Bothrops diporus antivenom production. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/42159745 | PubMed |
| 42084804 | Dual role of ascorbyl Palmitate as coagel and adjuvant in experimental antivenom development. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/42084804 | PubMed |
| 42080164 | Cooperative supramolecular integration of QS-21 into polymeric micelles as a tunable nanoadjuvant platform for subunit vaccines. | RSC Adv | 2026 | https://conductscience.org/library/papers/42080164 | PubMed |
| 42050105 | Graphene quantum dot-coated mesoporous silica loaded with glucosamine sulfate as a potent antigen delivery system for immunoactivation. | Commun Biol | 2026 | https://conductscience.org/library/papers/42050105 | PubMed |
| 41893753 | Investigating the In Vitro Immunomodulatory Potential of Microparticulate β-L-Adenosine in Particulate Vaccine Candidates. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41893753 | PubMed |
| 41891446 | Giardia unveiled: a proteome view of the parasite in search of drug, vaccine and diagnostic targets. | Parasitology | 2026 | https://conductscience.org/library/papers/41891446 | PubMed |
| 41859102 | Carbohydrate fatty acid monosulphate ester adjuvant enhances the immunogenicity of influenza antigens via TLR4/2-dependent mechanisms. | Front Immunol | 2026 | https://conductscience.org/library/papers/41859102 | PubMed |
| 41746093 | Challenges and Prospects in the Development of a Universal SARS-CoV-2 Vaccine. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41746093 | PubMed |
| 41680180 | Re-shaping the immune response to influenza vaccination in a host with immune memory from influenza infection. | NPJ Vaccines | 2026 | https://conductscience.org/library/papers/41680180 | PubMed |
Genes44
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36911719
GET https://conductscience.org/api/papers/v1/36911719/references?page=2